DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $192,000 | +120.7% | 743 | +150.2% | 0.22% | +88.0% |
| Q1 2022 | $87,000 | -77.9% | 297 | -77.0% | 0.12% | -73.9% |
| Q3 2021 | $393,000 | -22.6% | 1,290 | -43.6% | 0.45% | -32.5% |
| Q4 2020 | $508,000 | +50700.0% | 2,287 | +57075.0% | 0.66% | +33150.0% |
| Q3 2020 | $1,000 | -99.5% | 4 | -99.7% | 0.00% | -99.3% |
| Q2 2020 | $209,000 | +6.6% | 1,244 | -12.3% | 0.28% | -35.5% |
| Q1 2020 | $196,000 | +1533.3% | 1,419 | +1792.0% | 0.43% | +3466.7% |
| Q4 2019 | $12,000 | -61.3% | 75 | -66.5% | 0.01% | -61.3% |
| Q3 2019 | $31,000 | -91.0% | 224 | -90.8% | 0.03% | -91.5% |
| Q2 2019 | $346,000 | +578.4% | 2,422 | +527.5% | 0.36% | +506.7% |
| Q1 2019 | $51,000 | -37.8% | 386 | -51.6% | 0.06% | -57.1% |
| Q4 2018 | $82,000 | +4000.0% | 798 | +5600.0% | 0.14% | +4566.7% |
| Q3 2018 | $2,000 | -50.0% | 14 | -62.2% | 0.00% | -40.0% |
| Q2 2018 | $4,000 | -99.6% | 37 | -99.6% | 0.01% | -99.7% |
| Q1 2018 | $964,000 | +11.8% | 9,904 | +6.6% | 1.52% | +50.0% |
| Q4 2017 | $862,000 | +93.7% | 9,292 | +64.6% | 1.01% | -11.6% |
| Q2 2014 | $445,000 | +436.1% | 5,646 | +410.5% | 1.15% | +367.8% |
| Q1 2014 | $83,000 | +4050.0% | 1,106 | +3850.0% | 0.24% | +12150.0% |
| Q4 2013 | $2,000 | -84.6% | 28 | -85.5% | 0.00% | -83.3% |
| Q3 2013 | $13,000 | +8.3% | 193 | +6.0% | 0.01% | -7.7% |
| Q2 2013 | $12,000 | – | 182 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |